Lapas attēli
PDF
ePub
[blocks in formation]

None

Injection

American McGaw

Anesthetic

5-C

3-30-84

Lidocaine HCI & 5% Dextrose Injection

Verapamil NCI

Calan 1.V.

Vials

Sear le

Supraventricular Tachy-Arrhythmias

5-C

3-30-84

19-077

None

In jection

American McGaw

5-C-P

3-02-84

Sterile Water for
Injection, USP

Diluent for other
parentral drugs.

18-938

De smopressin Acetate

DDAVP Injection

Ampuls

Armour

3-B

3-30-84

Anti-diuretic used
to treat moderate
hemophillia.

18-907

Metronidazole

Red I- Infusion

Vial

Elkins-Sinn

5-C

3-30-84

Treatment of serious
infections caused by
susceptible anaerobic
bacteria.

18-967

18-704

Metoprolol

1.opressor

Injection

Ciba-Geigy

3-B

Anti-hypertensive
(Beta-Blocker)

3-30-84

18-925

19-038

Verapamil HCI

Calan 1.v.

Syringes

Searle Pharms

Supraventricular Tachy-Arrhythmias

5-C

3-30-84

[blocks in formation]

April 1984

[blocks in formation]

NDA!

18-985

19-004

19-006

18-921

18-901

18-849

18-977

18-858

18-776

Yecuronium Bromide

Morcuron (NC-45)

Injection

Organon Inc.

Neuromuscular block ing agent:

04-30-84 NDAS APP

DOSAGE
FORM

CLASSIF-
ICATION

APPRUTAL

TRADE NAME

APPLICANT

INDICATIONS

DATE

Micronase

Tablet

Upjohn

05-01-84

.

bia Beta

Tablet

Hoechst-Roussel

5-C

05-01-84

Hypoglycemia
Hypoglycemia
Neuromuscular blocking agent ;
Spinal anesthetic

Sufenta

05-04-84

Marcaine

3-C

Bupivacaine HCI .75% with Dextrose

05-04-84

Injection

Janssen
Spinal

Sterling
Injection
Capsule

Zenith Labs
Sustained Release Central
Capsule

None

Anti-inflammatory

5-C-U

05-04-84

None

Anti-allergic

. 5-C

05-04-84

Phenylpropanolamine HCI & Chlorpheniramine Maleate

[blocks in formation]

NDA!

GENERIC NAME

May 1984

17-498

Glyour ide
Glyour ide

17-532

19-050

Sufentan 11

18-692

18-730

Indomethacin

18-809

17-783

Tablet

18-556

61 ipizide

Glucotrol
Chlorpheniramine Maleate Demaz in
& Phenylpropanolamine HCI
Crystalline Amino Acids Aminosyn
Ibuprofen 200 mg.

Advil

18-804

18-989

Tablet

19-012

18-851

Indomethacin

50-579

Cefonicid Sodiun

50-554

Ceforan ide

* It has been determined that the modest advance rating will be attributed to the first application approved when two applications

are approved on the same date for the same use.

[merged small][merged small][merged small][ocr errors][merged small][merged small][merged small][merged small]

David Beier, Esq.
Subcommittee on courts, Civil Liberties

and the Administration of Justice
Committee on the Judiciary
2137 Rayburn Building
Washington, DC 20515

Subject:

Ad Hoc Group to Improve the Patent Laws --
Sections 5 and 6 of Proposed Legislation

Dear David:

Concurrent with our preparation of testimony, we are collecting materials in response to your inquiry about background for the items in our proposed patent legislation. One of the areas for which we are seeking legislative remedy has to do with the effect, on the patentability of subsequent inventions, of background scientific knowledge within an organization. This situation has led to conflicting judicial decisions over the past decade. Our concern is for the effect of such decisions on team research and the free exchange of scientific information within research organizations.

There has been extensive scholarly analysis of this situation, and several excellent reviews of the law have recently been published. Copies are enclosed. There is now extensive discussion within the bar associations of this issue, and several good suggestions have been made to improve the language of the Ad Hoc Group. We look forward to discussing this with you, because we would like to include all useful suggestions in the bill as introduced.

We will write to you separately on the other sections of the proposed bill.

[blocks in formation]

Encl. Shurn, "Is the Invention of Another Available as

Prior Art? In re Bass to In re Clemens and Beyond", 63 Journal of the Patent Office Society 516 (1981).

Walterscheid, "The Ever Evolving Meaning of Prior Art",

Part I, 64 J.P.0.8. 457 (1982)
Part II, 64 J.P.0.S. 571 (1982)
Part III, 64 J.P.0.8. 632 (1982)
Part IV, 65 J.P.O.S. 3 (1983)

Ad Hoc Group to Improve the Patent Laws

CC:

d51B5 md 73

« iepriekšējāTurpināt »